Dr. Paul Offit

And now the vaccine is going to be given to hundreds of millions of people and you're going to find out what you didn't think about. So your heart's always in your throat.

So I am still on the FDA vaccine advisory committee.

So I am still on the FDA vaccine advisory committee.

So I am still on the FDA vaccine advisory committee.

Okay, so you know that your recommendation is based on the question, do you know enough? not do you know everything. So, for example, in December 2020, we were confronted with, on the 10th, December 10th, with the Pfizer's vaccine, Pfizer's mRNA vaccine, and a week later, the mRNA vaccine for Moderna. The way that works is you get

Okay, so you know that your recommendation is based on the question, do you know enough? not do you know everything. So, for example, in December 2020, we were confronted with, on the 10th, December 10th, with the Pfizer's vaccine, Pfizer's mRNA vaccine, and a week later, the mRNA vaccine for Moderna. The way that works is you get

Okay, so you know that your recommendation is based on the question, do you know enough? not do you know everything. So, for example, in December 2020, we were confronted with, on the 10th, December 10th, with the Pfizer's vaccine, Pfizer's mRNA vaccine, and a week later, the mRNA vaccine for Moderna. The way that works is you get

For the first vaccine, you'll get 150 pages to 200 pages from the company where they go through all their phase one, phase two, phase three data, meaning bigger and bigger studies and ultimately the big definitive study, which was a 40,000-person prospective one-to-one placebo-controlled study. And then you also get 150 to 200 pages from

For the first vaccine, you'll get 150 pages to 200 pages from the company where they go through all their phase one, phase two, phase three data, meaning bigger and bigger studies and ultimately the big definitive study, which was a 40,000-person prospective one-to-one placebo-controlled study. And then you also get 150 to 200 pages from

For the first vaccine, you'll get 150 pages to 200 pages from the company where they go through all their phase one, phase two, phase three data, meaning bigger and bigger studies and ultimately the big definitive study, which was a 40,000-person prospective one-to-one placebo-controlled study. And then you also get 150 to 200 pages from

the FDA, where they review those data to see whether there's any omissions or misrepresentation. So you're reading 400 pages for that first meeting. And how long do you have to read 400 pages? About a week. And you read it. You read every word because your heart's in your throat. Because you really, you want to see if there's anything there. And there was.

the FDA, where they review those data to see whether there's any omissions or misrepresentation. So you're reading 400 pages for that first meeting. And how long do you have to read 400 pages? About a week. And you read it. You read every word because your heart's in your throat. Because you really, you want to see if there's anything there. And there was.

the FDA, where they review those data to see whether there's any omissions or misrepresentation. So you're reading 400 pages for that first meeting. And how long do you have to read 400 pages? About a week. And you read it. You read every word because your heart's in your throat. Because you really, you want to see if there's anything there. And there was.

We thought that there was a statistically, the numbers were small, but there was a statistically significant increase in Bell's palsy in the vaccinated group versus the unvaccinated, you know, one-sided facial paralysis. And so we were worried about that. I mean, that's a big price to pay for a disease that most people are going to get and not die from and not be permanently harmed by.

We thought that there was a statistically, the numbers were small, but there was a statistically significant increase in Bell's palsy in the vaccinated group versus the unvaccinated, you know, one-sided facial paralysis. And so we were worried about that. I mean, that's a big price to pay for a disease that most people are going to get and not die from and not be permanently harmed by.

We thought that there was a statistically, the numbers were small, but there was a statistically significant increase in Bell's palsy in the vaccinated group versus the unvaccinated, you know, one-sided facial paralysis. And so we were worried about that. I mean, that's a big price to pay for a disease that most people are going to get and not die from and not be permanently harmed by.

And as it turns out, when this vaccine was given to millions of people and there was enough on both sides to see, that went away. That wasn't a real problem. And then the next week, when you meet for Moderna's vaccine, you're getting another 400 pages to review. And you read every word because you're afraid you're going to miss something. And then you recommend authorization.

And as it turns out, when this vaccine was given to millions of people and there was enough on both sides to see, that went away. That wasn't a real problem. And then the next week, when you meet for Moderna's vaccine, you're getting another 400 pages to review. And you read every word because you're afraid you're going to miss something. And then you recommend authorization.

And as it turns out, when this vaccine was given to millions of people and there was enough on both sides to see, that went away. That wasn't a real problem. And then the next week, when you meet for Moderna's vaccine, you're getting another 400 pages to review. And you read every word because you're afraid you're going to miss something. And then you recommend authorization.

We're an advisory body, and you're in medicine. You know people can choose not to take your advice, and that's true of the FDA as well. But they authorize then through emergency use authorization this vaccine. But you're always... always waiting for the other shoe to drop, but it did drop.